<?xml version="1.0" encoding="UTF-8"?>
<protein>
  <version>3.5</version>
  <creation_date>2013-01-15 18:50:14 -0700</creation_date>
  <update_date>2013-04-11 15:13:01 -0600</update_date>
  <accession>HMDBP00446</accession>
  <secondary_accessions>
    <accession>5684</accession>
    <accession>HMDBP05632</accession>
  </secondary_accessions>
  <protein_type>Transporter</protein_type>
  <synonyms>
    <synonym>LST-2</synonym>
    <synonym>Liver-specific organic anion transporter 2</synonym>
    <synonym>OATP-8</synonym>
    <synonym>Organic anion transporter 8</synonym>
    <synonym>Organic anion-transporting polypeptide 8</synonym>
    <synonym>Solute carrier family 21 member 8</synonym>
  </synonyms>
  <gene_name>SLCO1B3</gene_name>
  <general_function>Involved in transporter activity</general_function>
  <specific_function>Mediates the Na(+)-independent transport of organic anions such as 17-beta-glucuronosyl estradiol, taurocholate, triiodothyronine (T3), leukotriene C4, dehydroepiandrosterone sulfate (DHEAS), methotrexate and sulfobromophthalein (BSP)</specific_function>
  <pathways>
  </pathways>
  <metabolite_associations>
    <metabolite>
      <accession>HMDB00307</accession>
      <name>1b-Hydroxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00308</accession>
      <name>3b-Hydroxy-5-cholenoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00311</accession>
      <name>3b,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00312</accession>
      <name>3a,7a,12b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00316</accession>
      <name>2b,3a,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00320</accession>
      <name>3a,4b,7a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00326</accession>
      <name>1b,3a,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00328</accession>
      <name>12-Ketodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00330</accession>
      <name>3a,4b,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00340</accession>
      <name>3a,7a,12a,19-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00348</accession>
      <name>3b,12a-Dihydroxy-5a-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00359</accession>
      <name>3a,7a-Dihydroxycoprostanic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00361</accession>
      <name>3b,7a-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00364</accession>
      <name>3a,6a,7b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00367</accession>
      <name>3a,6b,7b,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00371</accession>
      <name>1,3,12-Trihydroxycholan-24-oic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00376</accession>
      <name>3b,7a,12a-Trihydroxy-5a-Cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00377</accession>
      <name>3a,6b,7b,12b-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00381</accession>
      <name>Allolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00384</accession>
      <name>3a,7a-Dihydroxycholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00385</accession>
      <name>12a-Hydroxy-3-oxocholadienic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00390</accession>
      <name>3a,7b,12b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00391</accession>
      <name>7-Ketodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00395</accession>
      <name>3b,7b,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00399</accession>
      <name>3a,6b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00400</accession>
      <name>3,7-Dihydroxy-12-oxocholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00404</accession>
      <name>2b,3a,7a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00411</accession>
      <name>3a,12b-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00414</accession>
      <name>1b,3a,7a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00415</accession>
      <name>3a,6b,7b-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00419</accession>
      <name>3b,7a,12a-Trihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00427</accession>
      <name>3b,7b,12a-Trihydroxy-5a-Cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00432</accession>
      <name>3a,7b,12a-Trihydroxy-5a-Cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00433</accession>
      <name>1,3,7,12-Tetrahydroxycholan-24-oic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00437</accession>
      <name>3a,4b,7a,12a-Tetrahydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00438</accession>
      <name>3b,12a-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00447</accession>
      <name>7a,12a-Dihydroxy-3-oxo-4-cholenoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00460</accession>
      <name>7-Hydroxy-3-oxocholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00467</accession>
      <name>Nutriacholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00476</accession>
      <name>3-Oxo-4,6-choladienoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00478</accession>
      <name>Allodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00502</accession>
      <name>3-Oxocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00503</accession>
      <name>7a-Hydroxy-3-oxo-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00505</accession>
      <name>Allocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00506</accession>
      <name>Alpha-Muricholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00514</accession>
      <name>Allochenodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00518</accession>
      <name>Chenodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00527</accession>
      <name>6a,12a-Dihydroxylithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00545</accession>
      <name>Chenodeoxycholic acid disulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00601</accession>
      <name>Coprocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00619</accession>
      <name>Cholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00626</accession>
      <name>Deoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00659</accession>
      <name>Deoxycholic acid disulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00664</accession>
      <name>Isohyodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00686</accession>
      <name>Isoursodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00713</accession>
      <name>Isoallolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00717</accession>
      <name>Isolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00733</accession>
      <name>Hyodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00760</accession>
      <name>Hyocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00761</accession>
      <name>Lithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00811</accession>
      <name>Murocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00865</accession>
      <name>Muricholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00907</accession>
      <name>Sulfolithocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00917</accession>
      <name>Ursocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00946</accession>
      <name>Ursodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB01181</accession>
      <name>4a-Carboxy-4b-methyl-5a-cholesta-8,24-dien-3b-ol</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02082</accession>
      <name>Bisnorcholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02163</accession>
      <name>Trihydroxycoprostanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02195</accession>
      <name>Varanic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02421</accession>
      <name>7-Sulfocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02430</accession>
      <name>(3a,5b,7a)-23-Carboxy-7-hydroxy-24-norcholan-3-yl-b-D-Glucopyranosiduronic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02431</accession>
      <name>12b-Hydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02451</accession>
      <name>7b,12a-Dihydroxycholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02488</accession>
      <name>7a,12b-dihydroxy-5b-Cholan-24-oic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02492</accession>
      <name>7a-Hydroxy-5b-cholanic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02497</accession>
      <name>Glycochenodeoxycholate-3-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02504</accession>
      <name>3-Sulfodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02522</accession>
      <name>Chenodeoxycholic acid sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02536</accession>
      <name>Isodeoxycholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02585</accession>
      <name>3b,12b-Dihydroxy-5b-cholanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02586</accession>
      <name>Chenodeoxycholic acid 3-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB02642</accession>
      <name>Ursodeoxycholic acid 3-sulfate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB03873</accession>
      <name>3a,7a,12a-Trihydroxy-5b-cholestanoic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB06898</accession>
      <name>Chenodeoxyglycocholic acid</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00077</accession>
      <name>Dehydroepiandrosterone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB13848</accession>
      <name>4-Hydroxyvalsartan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14420</accession>
      <name>Olmesartan</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14534</accession>
      <name>Digoxin n</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14661</accession>
      <name>Caspofungin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB14703</accession>
      <name>Methotrexate</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15179</accession>
      <name>Rifampin</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15224</accession>
      <name>Ouabain</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15264</accession>
      <name>Pioglitazone</name>
    </metabolite>
    <metabolite>
      <accession>HMDB15523</accession>
      <name>Liotrix</name>
    </metabolite>
    <metabolite>
      <accession>HMDB00036</accession>
      <name>Taurocholic acid</name>
    </metabolite>
  </metabolite_associations>
  <go_classifications>
    <go_class>
      <category>function</category>
      <description>transporter activity</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>establishment of localization</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>process</category>
      <description>transport</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>cell part</description>
      <go_id/>
    </go_class>
    <go_class>
      <category>component</category>
      <description>membrane</description>
      <go_id/>
    </go_class>
  </go_classifications>
  <subcellular_locations>
    <subcellular_location>Basal cell membrane</subcellular_location>
    <subcellular_location>Multi-pass membrane protein</subcellular_location>
    <subcellular_location>Lateral cell membrane</subcellular_location>
    <subcellular_location>Multi-pass membrane protein</subcellular_location>
  </subcellular_locations>
  <gene_properties>
    <chromosome_location>Chromosome:1</chromosome_location>
    <locus>12p12</locus>
    <gene_sequence>&gt;2109 bp
ATGGACCAACATCAACATTTGAATAAAACAGCAGAGTCAGCATCTTCAGAGAAAAAGAAA
ACAAGACGCTGCAATGGATTCAAGATGTTCTTGGCAGCCCTGTCATTCAGCTATATTGCT
AAAGCACTAGGTGGAATCATTATGAAAATTTCCATCACTCAAATAGAAAGGAGATTTGAC
ATATCCTCTTCTCTTGCTGGTTTAATTGATGGAAGCTTTGAAATTGGAAATTTGCTTGTG
ATTGTATTTGTAAGTTACTTTGGATCTAAACTACACAGACCGAAGTTAATTGGAATTGGT
TGTCTCCTTATGGGAACTGGAAGTATTTTGACATCTTTACCACATTTCTTCATGGGATAT
TATAGGTATTCTAAAGAAACCCATATTAATCCATCAGAAAATTCAACATCAAGTTTATCA
ACCTGTTTAATTAATCAAACCTTATCATTCAATGGAACATCACCTGAGATAGTAGAAAAA
GATTGTGTAAAGGAATCTGGGTCACACATGTGGATCTATGTCTTCATGGGGAATATGCTT
CGTGGCATAGGGGAAACCCCCATAGTACCATTGGGGATTTCATACATTGATGATTTTGCA
AAAGAAGGACATTCTTCCTTGTATTTAGGTAGTTTGAATGCAATAGGAATGATTGGTCCA
GTCATTGGCTTTGCACTGGGATCTCTGTTTGCTAAAATGTACGTGGATATTGGATATGTA
GATCTGAGCACTATCAGAATAACTCCTAAGGACTCTCGTTGGGTTGGAGCTTGGTGGCTT
GGTTTCCTTGTGTCTGGACTATTTTCCATTATTTCTTCCATACCATTTTTTTTCTTGCCG
AAAAATCCAAATAAACCACAAAAAGAAAGAAAAATTTCACTATCATTGCATGTGCTGAAA
ACAAATGATGATAGAAATCAAACAGCTAATTTGACCAACCAAGGAAAAAATGTTACCAAA
AATGTGACTGGTTTTTTCCAGTCTTTGAAAAGCATCCTTACCAATCCCCTGTATGTTATA
TTTCTGCTTTTGACATTGTTACAAGTAAGCAGCTTTATTGGTTCTTTTACTTACGTCTTT
AAATATATGGAGCAACAGTACGGTCAGTCTGCATCTCATGCTAACTTTTTGTTGGGAATC
ATAACCATTCCTACGGTTGCAACTGGAATGTTTTTAGGAGGATTTATCATTAAAAAATTC
AAATTGTCTTTAGTTGGAATTGCCAAATTTTCATTTCTTACTTCGATGATATCCTTCTTG
TTTCAACTTCTATATTTCCCTCTAATCTGCGAAAGCAAATCAGTTGCCGGCCTAACCTTG
ACCTATGATGGAAATAATTCAGTGGCATCTCATGTAGATGTACCACTTTCTTATTGCAAC
TCAGAGTGCAATTGTGATGAAAGTCAGTGGGAACCAGTCTGTGGGAACAATGGAATAACT
TACCTGTCACCTTGTCTAGCAGGATGCAAATCCTCAAGTGGTATTAAAAAGCATACAGTG
TTTTATAACTGTAGTTGTGTGGAAGTAACTGGTCTCCAGAACAGAAATTACTCAGCACAC
TTGGGTGAATGCCCAAGAGATAATACTTGTACAAGGAAATTTTTCATCTATGTTGCAATT
CAAGTCATAAACTCTTTGTTCTCTGCAACAGGAGGTACCACATTTATCTTGTTGACTGTG
AAGATTGTTCAACCTGAATTGAAAGCACTTGCAATGGGTTTCCAGTCAATGGTTATAAGA
ACACTAGGAGGAATTCTAGCTCCAATATATTTTGGGGCTCTGATTGATAAAACATGTATG
AAGTGGTCCACCAACAGCTGTGGAGCACAAGGAGCTTGTAGGATATATAATTCCGTATTT
TTTGGAAGGGTCTACTTGGGCTTATCTATAGCTTTAAGATTCCCAGCACTTGTTTTATAT
ATTGTTTTCATTTTTGCTATGAAGAAAAAATTTCAAGGAAAAGATACCAAGGCATCGGAC
AATGAAAGAAAAGTAATGGATGAAGCAAACTTAGAATTCTTAAATAATGGTGAACATTTT
GTACCTTCTGCTGGAACAGATAGTAAAACATGTAATTTGGACATGCAAGACAATGCTGCT
GCCAACTAA</gene_sequence>
  </gene_properties>
  <protein_properties>
    <residue_number>702</residue_number>
    <molecular_weight>77402.2</molecular_weight>
    <theoretical_pi>8.95</theoretical_pi>
    <pfams>
      <pfam>
        <name>Kazal_2</name>
        <pfam_id>PF07648</pfam_id>
      </pfam>
      <pfam>
        <name>OATP</name>
        <pfam_id>PF03137</pfam_id>
      </pfam>
    </pfams>
    <transmembrane_regions>
      <region>30-50</region>
      <region>65-85</region>
      <region>97-117</region>
      <region>171-191</region>
      <region>207-227</region>
      <region>259-279</region>
      <region>336-356</region>
      <region>377-397</region>
      <region>410-430</region>
      <region>538-558</region>
      <region>575-595</region>
      <region>626-646</region>
    </transmembrane_regions>
    <signal_regions>
      <region>None</region>
    </signal_regions>
    <protein_sequence>&gt;Solute carrier organic anion transporter family member 1B3
MDQHQHLNKTAESASSEKKKTRRCNGFKMFLAALSFSYIAKALGGIIMKISITQIERRFD
ISSSLAGLIDGSFEIGNLLVIVFVSYFGSKLHRPKLIGIGCLLMGTGSILTSLPHFFMGY
YRYSKETHINPSENSTSSLSTCLINQTLSFNGTSPEIVEKDCVKESGSHMWIYVFMGNML
RGIGETPIVPLGISYIDDFAKEGHSSLYLGSLNAIGMIGPVIGFALGSLFAKMYVDIGYV
DLSTIRITPKDSRWVGAWWLGFLVSGLFSIISSIPFFFLPKNPNKPQKERKISLSLHVLK
TNDDRNQTANLTNQGKNVTKNVTGFFQSLKSILTNPLYVIFLLLTLLQVSSFIGSFTYVF
KYMEQQYGQSASHANFLLGIITIPTVATGMFLGGFIIKKFKLSLVGIAKFSFLTSMISFL
FQLLYFPLICESKSVAGLTLTYDGNNSVASHVDVPLSYCNSECNCDESQWEPVCGNNGIT
YLSPCLAGCKSSSGIKKHTVFYNCSCVEVTGLQNRNYSAHLGECPRDNTCTRKFFIYVAI
QVINSLFSATGGTTFILLTVKIVQPELKALAMGFQSMVIRTLGGILAPIYFGALIDKTCM
KWSTNSCGAQGACRIYNSVFFGRVYLGLSIALRFPALVLYIVFIFAMKKKFQGKDTKASD
NERKVMDEANLEFLNNGEHFVPSAGTDSKTCNLDMQDNAAAN</protein_sequence>
  </protein_properties>
  <genbank_protein_id>9187497</genbank_protein_id>
  <uniprot_id>Q9NPD5</uniprot_id>
  <uniprot_name>SO1B3_HUMAN</uniprot_name>
  <pdb_ids>
  </pdb_ids>
  <genbank_gene_id>AJ251506</genbank_gene_id>
  <genecard_id>SLCO1B3</genecard_id>
  <geneatlas_id>SLCO1B3</geneatlas_id>
  <hgnc_id>HGNC:10961</hgnc_id>
  <general_references>
    <reference>
      <reference_text>Konig J, Cui Y, Nies AT, Keppler D: Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem. 2000 Jul 28;275(30):23161-8.</reference_text>
      <pubmed_id>10779507</pubmed_id>
    </reference>
    <reference>
      <reference_text>Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99.</reference_text>
      <pubmed_id>11375950</pubmed_id>
    </reference>
    <reference>
      <reference_text>Sjoblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers.  Science. 2006 Oct 13;314(5797):268-74. Epub 2006 Sep 7.</reference_text>
      <pubmed_id>16959974</pubmed_id>
    </reference>
  </general_references>
  <metabolite_references>
    <metabolite_reference>
      <metabolite>
        <name>Cholic acid</name>
        <accession>HMDB00619</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Leier I, Buchholz U, Keppler D: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. Epub 2000 Dec 27.</reference_text>
        <pubmed_id>11134001</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4-Hydroxyvalsartan</name>
        <accession>HMDB13848</accession>
      </metabolite>
      <reference>
        <reference_text>Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in human based on in vitro uptake transport data. J Pharmacokinet Pharmacodyn. 2009 Dec;36(6):585-611. Epub 2009 Nov 20.</reference_text>
        <pubmed_id>19936896</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>4-Hydroxyvalsartan</name>
        <accession>HMDB13848</accession>
      </metabolite>
      <reference>
        <reference_text>Poirier A, Cascais AC, Funk C, Lave T: Prediction of pharmacokinetic profile of valsartan in humans based on in vitro uptake-transport data. Chem Biodivers. 2009 Nov;6(11):1975-87.</reference_text>
        <pubmed_id>19937834</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Olmesartan</name>
        <accession>HMDB14420</accession>
      </metabolite>
      <reference>
        <reference_text>Nakagomi-Hagihara R, Nakai D, Kawai K, Yoshigae Y, Tokui T, Abe T, Ikeda T: OATP1B1, OATP1B3, and mrp2 are involved in hepatobiliary transport of olmesartan, a novel angiotensin II blocker. Drug Metab Dispos. 2006 May;34(5):862-9. Epub 2006 Feb 24.</reference_text>
        <pubmed_id>16501004</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Digoxin n</name>
        <accession>HMDB14534</accession>
      </metabolite>
      <reference>
        <reference_text>Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.</reference_text>
        <pubmed_id>11159893</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Caspofungin</name>
        <accession>HMDB14661</accession>
      </metabolite>
      <reference>
        <reference_text>Sandhu P, Lee W, Xu X, Leake BF, Yamazaki M, Stone JA, Lin JH, Pearson PG, Kim RB: Hepatic uptake of the novel antifungal agent caspofungin.  Drug Metab Dispos. 2005 May;33(5):676-82. Epub 2005 Feb 16.</reference_text>
        <pubmed_id>15716364</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Methotrexate</name>
        <accession>HMDB14703</accession>
      </metabolite>
      <reference>
        <reference_text>Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99.</reference_text>
        <pubmed_id>11375950</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Leier I, Buchholz U, Keppler D: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. Epub 2000 Dec 27.</reference_text>
        <pubmed_id>11134001</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Vavricka SR, Van Montfoort J, Ha HR, Meier PJ, Fattinger K: Interactions of rifamycin SV and rifampicin with organic anion uptake systems of human liver. Hepatology. 2002 Jul;36(1):164-72.</reference_text>
        <pubmed_id>12085361</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Rifampin</name>
        <accession>HMDB15179</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Keppler D: Vectorial transport by double-transfected cells expressing the human uptake transporter SLC21A8 and the apical export pump ABCC2. Mol Pharmacol. 2001 Nov;60(5):934-43.</reference_text>
        <pubmed_id>11641421</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Ouabain</name>
        <accession>HMDB15224</accession>
      </metabolite>
      <reference>
        <reference_text>Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.</reference_text>
        <pubmed_id>11159893</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Pioglitazone</name>
        <accession>HMDB15264</accession>
      </metabolite>
      <reference>
        <reference_text>Nozawa T, Sugiura S, Nakajima M, Goto A, Yokoi T, Nezu J, Tsuji A, Tamai I: Involvement of organic anion transporting polypeptides in the transport of troglitazone sulfate: implications for understanding troglitazone hepatotoxicity. Drug Metab Dispos. 2004 Mar;32(3):291-4.</reference_text>
        <pubmed_id>14977862</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Liotrix</name>
        <accession>HMDB15523</accession>
      </metabolite>
      <reference>
        <reference_text>Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.</reference_text>
        <pubmed_id>11159893</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Liotrix</name>
        <accession>HMDB15523</accession>
      </metabolite>
      <reference>
        <reference_text>Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99.</reference_text>
        <pubmed_id>11375950</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Cui Y, Konig J, Leier I, Buchholz U, Keppler D: Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001 Mar 30;276(13):9626-30. Epub 2000 Dec 27.</reference_text>
        <pubmed_id>11134001</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Kullak-Ublick GA, Ismair MG, Stieger B, Landmann L, Huber R, Pizzagalli F, Fattinger K, Meier PJ, Hagenbuch B: Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology. 2001 Feb;120(2):525-33.</reference_text>
        <pubmed_id>11159893</pubmed_id>
      </reference>
    </metabolite_reference>
    <metabolite_reference>
      <metabolite>
        <name>Taurocholic acid</name>
        <accession>HMDB00036</accession>
      </metabolite>
      <reference>
        <reference_text>Abe T, Unno M, Onogawa T, Tokui T, Kondo TN, Nakagomi R, Adachi H, Fujiwara K, Okabe M, Suzuki T, Nunoki K, Sato E, Kakyo M, Nishio T, Sugita J, Asano N, Tanemoto M, Seki M, Date F, Ono K, Kondo Y, Shiiba K, Suzuki M, Ohtani H, Shimosegawa T, Iinuma K, Nagura H, Ito S, Matsuno S: LST-2, a human liver-specific organic anion transporter, determines methotrexate sensitivity in gastrointestinal cancers. Gastroenterology. 2001 Jun;120(7):1689-99.</reference_text>
        <pubmed_id>11375950</pubmed_id>
      </reference>
    </metabolite_reference>
  </metabolite_references>
</protein>
